OPKO Health (OPK) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the ...

It posted a beat-and-raise second quarter.

On July 27, OPKO Health, Inc. released its Q2 numbers. So, OPK's revenue from transfer of IP and other increased 208% YoY to ...

OPKO Health (NASDAQ:OPK) is back in focus. Explore its latest update, the penny stocks backdrop, execution priorities, and ...

OPKO Health, Inc. OPK reported a second-quarter 2026 loss of 1 cent per share, narrower than the year-ago quarter's loss of ...

Opko Health beat earnings and raised guidance, but one-off gains mask weak core trends. Click here to read more about OPK.

Reaches 52 Week High On Second Quarter News. ) a trusted platform for investing ideas, including biotech and medical tech stocks, issues a news and trading alert for OPKO Health, Inc. (NASDAQ: OPK ), ...

Longtime investor OPKO Health increases its position as Cocrystal advances toward norovirus Phase 1b data in late 2026BOTHELL ...

Opko Health () has held its Q2 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks. Unlock powerful investing tools with TipRanks Premium to make sm ...

OPKO Health (OPK) reported $163.5 million in revenue for the quarter ended June 2026, representing a year-over-year increase ...